Dr. Frank Mühlenbeck brings 20+ years of experience in venture capital investing to the team. From 2015 to 2023 he managed investments in life science companies at EMBL Ventures, a venture capital firm associated with the European Molecular Biology Laboratory (www.embl.de). Before that Frank was founding partner of a large family office in Switzerland where he was responsible for public- and private life science investments in Europe and the US. His transaction experience covers M&A’s as well as IPO’s (Euronext, NASDAQ). Frank started his career after his PhD in basic tumor research at Steinbeis, a German technology transfer organization with headquarters in Stuttgart. In his free time, he enjoys time with his family, plays E-Guitar, runs and rides motorcycles.